Sailong Pharmaceuticals: Subsidiary Sailong Pharmaceutical Co., Ltd. in Hunan Province obtains the registration certificate for aminophylline injection.

Sailong announces that its wholly-owned subsidiary, Hunan Sailong Pharmaceutical Co., Ltd., recently obtained the "Drug Registration Certificate" issued by the National Medical Products Administration for the approval of Aminophylline Injection. Aminophylline Injection is mainly used to treat bronchial asthma, chronic obstructive pulmonary disease, and relieve asthma symptoms; it can also be used to treat heart failure and cardiac asthma.